Landy Toth Files SC 13D on Autonomix Medical Stock

TL;DR

**Landy Toth just disclosed a major stake in Autonomix Medical, watch for potential moves!**

AI Summary

Landy Toth filed a Schedule 13D on February 26, 2024, indicating an event on January 26, 2024, that required the filing. The filing concerns Autonomix Medical, Inc. (CIK: 0001617867), a surgical and medical instruments company, and relates to their Common Stock (CUSIP: 05330T 106). The filing was made by Toth Landy (CIK: 0002012435).

Why It Matters

This filing signals a significant ownership stake or change in beneficial ownership by Landy Toth in Autonomix Medical, Inc., which could influence the company's future direction or stock performance.

Risk Assessment

Risk Level: medium — A Schedule 13D indicates a beneficial ownership of over 5%, which can lead to activist investor actions or significant influence on company decisions.

Key Players & Entities

• Autonomix Medical, Inc. (company) — Subject Company
• Landy Toth (person) — Filing Person
• Toth Landy (company) — Filing Organization
• January 26, 2024 (date) — Date of Event Requiring Filing
• February 26, 2024 (date) — Filing Date

FAQ

Key Financial Figures

• $0.001 — o the shares of common stock, par value $0.001 per share (the “Common Stock&rdqu
• $187,500 — y the Reporting Person a base salary of $187,500 per year and issued the Reporting Perso

Filing Documents

• toth_13d.htm (SC 13D) — 41KB
• 0001683168-24-001176.txt ( ) — 43KB

below summarizes the agreements pursuant

Item 4 below summarizes the agreements pursuant to which the securities beneficially owned by the Reporting Person were acquired. Item 4. Purpose of Transaction. In January 2022, the Issuer entered into a consulting agreement with the Reporting Person. Pursuant to the consulting agreement, the Issuer agreed to pay the Reporting Person a base salary of $187,500 per year and issued the Reporting Person a stock grant of 1,550,000 shares of common stock. In connection with the Issuer’s initial public offering, the Reporting Person entered into a lock-up agreement with the selling agent for the offering for a period of 180 days from the closing of the offering. CUSIP No. 05330T 106 13D Page 3 of 5 pages Item 5. Interest in Securities of the Issuer. (a) – (b) · Amount beneficially owned: 2,026,280 · Percent of Class: 10.8% · Number of shares the Reporting Person has: ○ Sole power to vote or direct the vote: 2,026,280 ○ Shared power to vote: 0 ○ Sole power to dispose or direct the disposition of: 2,026,280 ○ Shared power to dispose or direct the disposition of: 0 The above percentage is based on 18,811,094 shares of common stock outstanding as of February 26, 2024. (c) Except as described in Item 4, during the past 60 days, the Reporting Person has not effected any transactions with respect to the Common Stock. (d) None. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

above summarizes certain provisions of the

Item 4 above summarizes certain provisions of the Lock-Up Agreement and is incorporated herein by reference. A copy of such agreement is attached as an exhibit to this Schedule 13D and is incorporated herein by reference. The Reporting Person does not have any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to any contracts, arrangements, understandings or relationships concerning the transfer or voting of such securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies. CUSIP No. 05330T 106 13D Page 4 of 5 pages Item 7. Materials to be Filed as Exhibits. Exhibit Number Description 1 Form of Lock-Up Agreement (incorporated by reference to Exhibit 6.7 of the Issuer’s Form 1-A/A filed number 024-12296 filed on August 22, 2023). 5 CUSIP No. 05330T 106 13D Page 5 of 5 pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : February 26, 2024 By: /s/ Landy Toth Name: Landy Toth

View Full Filing

View this SC 13D filing on SEC EDGAR